Evidence map›Paper›PMID 31484725›Full record

ArticleThe Journal of biological chemistry2019

The SH3 domains of the protein kinases ITK and LCK compete for adjacent sites on T cell-specific adapter protein.

Thorny Cesilie Bie Andersen, Per Eugen Kristiansen, Zsuzsa Huszenicza, Maria U Johansson, Ramakrishna Prabhu Gopalakrishnan, Hanna Kjelstrup, Scott Boyken, Vibeke Sundvold-Gjerstad, Stine Granum, Morten Sørli and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Thorny Cesilie Bie AndersenInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway.
Per Eugen KristiansenDepartment of Biosciences, University of Oslo, 0317 Oslo, Norway.
Zsuzsa HuszeniczaInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway.
Maria U JohanssonSwedish NMR Centre at the University of Gothenburg, Gothenburg 413 90, Sweden.
Ramakrishna Prabhu GopalakrishnanInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway.
Hanna KjelstrupInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway.
Scott BoykenRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, Iowa 50011-1079.
Vibeke Sundvold-GjerstadInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway.
Stine GranumInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway.
Morten SørliDepartment of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, 1432 Ås, Norway.
Paul Hoff BackeDepartment of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.
D Bruce FultonRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, Iowa 50011-1079.
B Göran KarlssonSwedish NMR Centre at the University of Gothenburg, Gothenburg 413 90, Sweden.
Amy H AndreottiRoy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, Iowa 50011-1079.
Anne SpurklandInstitute of Basic Medical Sciences, Department of Molecular Medicine, University of Oslo, 0317 Oslo, Norway anne.spurkland@medisin.uio.no.ORCID 0000-0003-4421-0766
University of Oslo · NOIowa State University · USUniversity of Gothenburg · SENorwegian University of Life Sciences · NOOslo University Hospital · NO

Funding

STRUCTURAL STUDIES OF A T CELL SPECIFIC TYROSINE KINASER01AI043957 · NIAID · IOWA STATE UNIVERSITY · PI AMY H ANDREOTTI, LESLIE JOAN BERG · 1999 to 2026
$9.5M
NIAID NIH HHS R01 AI043957
6 · The paper itself

Abstract

T-cell activation requires stimulation of specific intracellular signaling pathways in which protein-tyrosine kinases, phosphatases, and adapter proteins interact to transmit signals from the T-cell receptor to the nucleus. Interactions of LCK proto-oncogene, SRC family tyrosine kinase (LCK), and the IL-2-inducible T cell kinase (ITK) with the T cell-specific adapter protein (TSAD) promotes LCK-mediated phosphorylation and thereby ITK activation. Both ITK and LCK interact with TSAD's proline-rich region (PRR) through their Src homology 3 (SH3) domains. Whereas LCK may also interact with TSAD through its SH2 domain, ITK interacts with TSAD only through its SH3 domain. To begin to understand on a molecular level how the LCK SH3 and ITK SH3 domains interact with TSAD in human HEK293T cells, here we combined biochemical analyses with NMR spectroscopy. We found that the ITK and LCK SH3 domains potentially have adjacent and overlapping binding sites within the TSAD PRR amino acids (aa) 239-274. Pulldown experiments and NMR spectroscopy revealed that both domains may bind to TSAD aa 239-256 and aa 257-274. Co-immunoprecipitation experiments further revealed that both domains may also bind simultaneously to TSAD aa 242-268. Accordingly, NMR spectroscopy indicated that the SH3 domains may compete for these two adjacent binding sites. We propose that once the associations of ITK and LCK with TSAD promote the ITK and LCK interaction, the interactions among TSAD, ITK, and LCK are dynamically altered by ITK phosphorylation status.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid MotifsHEK293 CellsHumansLymphocyte Specific Protein Tyrosine Kinase p56(lck)PhosphorylationProtein BindingProtein-Tyrosine KinasesProto-Oncogene Massrc Homology DomainsAdaptor Proteins, Signal Transducingemt protein-tyrosine kinaseLCK protein, humanLymphocyte Specific Protein Tyrosine Kinase p56(lck)MAS1 protein, humanProtein-Tyrosine KinasesProto-Oncogene MasSH2D2A protein, humanadaptor proteincell signalingIL-2-inducible T cell kinase (ITK)immunityLCK proto-oncogene SRC family tyrosine kinaseNMRnuclear magnetic resonanceprotein kinaseprotein phosphorylationprotein-protein interactionprotein structureSH2D2ASrc homology 3 domain (SH3 domain)T-cellT cell-specific adapter protein (TSAD)tyrosine-protein kinase

Identifiers

PMID31484725
PMCPMC6802506
OpenAlexW2971364607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.